SCHEMBL15722177

SCHEMBL15722177

Cc1cnn(-c2nc3ccccc3nc2N)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ NUDT1 P36639 1/20 0.46
▸ KDM4E B2RXH2 2/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ PDE10A Q9Y233 4/20 0.43
▸ TDO2 P48775 1/20 0.41
▸ ADORA2A P29274 6/20 0.40
▸ ADORA1 P30542 5/20 0.40
▸ ADORA3 P0DMS8 4/20 0.40
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12629776 0.79 MAPT (0.45) MAPTCYP1A2CYP2C9CYP2C19NUDT1
SCHEMBL25545962 0.69 TDO2 (0.46) MAPTCYP1A2KDM4EMAPK1NPSR1
SCHEMBL2547017 0.68 ADORA2A (0.53) MAPTKDM4EMAPK1NPSR1L3MBTL1
SCHEMBL255496 0.67 GAA (0.59) MAPTCYP1A2KDM4EMAPK1NPSR1
SCHEMBL26522667 0.67 TDO2 (0.44) MAPTCYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL16547470 0.67 HRH4 (0.48) MAPTCYP1A2CYP2C19KDM4EMAPK1
SCHEMBL4895758 0.66 KDM4E (0.49) MAPTCYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL29444102 0.65 MAPT (1.00) MAPTCYP1A2CYP2C9CYP2C19NUDT1
SCHEMBL503252 0.65 MAPT (1.00) MAPTCYP1A2CYP2C9CYP2C19NUDT1
SCHEMBL17066470 0.65 TDO2 (0.49) MAPTCYP1A2KDM4EMAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282999-B1 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2A RECEPTOR ANTAGONISTS MERCK SHARP & DOHME (US) 2014-05-21 — — EP disclosed
Send feedback